FDA Roundup: July 23, 2024

News Healthcare & Pharma English General Updates

Date: 23rd Jul, 2024 Source: Food and Drug Administration (FDA) Country: USA Original Source

Brief

For Immediate Release: July 23, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Â On Monday, the FDA approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating tablet approved for the prevention of pregnancy. Norethindrone acetate and ethinyl estradiol, the main ingredients in

This content is restricted.

Highlights content goes here...

This content is restricted.

Food and Drug Administration (FDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

FDA Roundup: July 23, 2024

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

FDA Roundup: July 23, 2024

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.